Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minocycline for Neuroimmune Dysfunction in Alcohol Use Disorder
NCT04210713Phase 1Completed
- Sponsor
- University of Maryland, Baltimore
- Start
- Feb 2020
- Primary completion
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of minocycline in alcohol use disorder (AUD), sponsored by University of Maryland, Baltimore. Started Feb 2020; status: completed.
02
Drugs
minocycline
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT04210713.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04210713.